- Home
- KMDA vs NATH Comparison
KMDA vs NATH Comparison
Compare KMDA & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- NATH
- Stock Information
- Founded
- KMDA 1990
- NATH 1916
- Country
- KMDA Israel
- NATH United States
- Employees
- KMDA N/A
- NATH N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- KMDA Health Care
- NATH Consumer Discretionary
- Exchange
- KMDA Nasdaq
- NATH Nasdaq
- Market Cap
- KMDA 426.0M
- NATH 385.4M
- IPO Year
- KMDA N/A
- NATH N/A
- Fundamental
- Price
- KMDA $6.71
- NATH $95.73
- Analyst Decision
- KMDA Strong Buy
- NATH
- Analyst Count
- KMDA 3
- NATH 0
- Target Price
- KMDA $14.67
- NATH N/A
- AVG Volume (30 Days)
- KMDA 139.3K
- NATH 10.5K
- Earning Date
- KMDA 03-05-2025
- NATH 02-06-2025
- Dividend Yield
- KMDA 2.99%
- NATH 2.09%
- EPS Growth
- KMDA 66.67
- NATH 24.88
- EPS
- KMDA 0.25
- NATH 5.80
- Revenue
- KMDA $160,953,000.00
- NATH $146,386,000.00
- Revenue This Year
- KMDA $11.45
- NATH N/A
- Revenue Next Year
- KMDA $9.94
- NATH N/A
- P/E Ratio
- KMDA $26.77
- NATH $16.61
- Revenue Growth
- KMDA 12.93
- NATH 6.83
- 52 Week Low
- KMDA $4.74
- NATH $64.02
- 52 Week High
- KMDA $9.15
- NATH $104.96
- Technical
- Relative Strength Index (RSI)
- KMDA 44.68
- NATH 56.24
- Support Level
- KMDA $6.44
- NATH $92.64
- Resistance Level
- KMDA $7.17
- NATH $97.00
- Average True Range (ATR)
- KMDA 0.20
- NATH 1.76
- MACD
- KMDA -0.02
- NATH -0.19
- Stochastic Oscillator
- KMDA 37.36
- NATH 88.84
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.